Quarterly report pursuant to Section 13 or 15(d)

Segment Reporting (Details)

v3.3.1.900
Segment Reporting (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2015
Dec. 31, 2014
Jun. 30, 2015
Segment Reporting Information [Line Items]          
Net revenues $ 134 $ 367 $ 294 $ 1,186  
Research and development expenses 704 731 1,255 1,916  
General and administrative expenses 1,684 1,302 3,106 2,352  
Operating loss (2,254) (1,666) (4,067) (3,082)  
Total assets 9,416   9,416   $ 12,494
iBio Brazil [Member]          
Segment Reporting Information [Line Items]          
Net revenues 0 0 0 0  
Research and development expenses 0 0 0 0  
General and administrative expenses 6 30 12 51  
Operating loss (6) (30) (12) (51)  
Total assets 25   25   46
iBio [Member]          
Segment Reporting Information [Line Items]          
Net revenues 134 367 294 1,186  
Research and development expenses 704 731 1,255 1,916  
General and administrative expenses 1,678 1,272 3,094 2,301  
Operating loss (2,248) $ (1,636) (4,055) $ (3,031)  
Total assets $ 9,391   $ 9,391   $ 12,448